University of Adelaide
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1874-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.adelaide.edu.au
Clinical Trials
42
Active:0
Completed:24
Trial Phases
5 Phases
Phase 1:1
Phase 2:3
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
Not Applicable
24 (80.0%)Phase 2
3 (10.0%)Phase 1
1 (3.3%)Phase 3
1 (3.3%)Phase 4
1 (3.3%)Effects of Combined Administration of Calcium and L-tryptophan on Gut Functions and Blood Glucose in Healthy Humans
Not Applicable
Not yet recruiting
- Conditions
- Healthy
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- University of Adelaide
- Target Recruit Count
- 16
- Registration Number
- NCT07013656
- Locations
- 🇦🇺
Clinical Research Facility, Adelaide Health and Medical Sciences Building, Adelaide, South Australia, Australia
Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes
Not Applicable
Not yet recruiting
- Conditions
- T2DM
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- University of Adelaide
- Target Recruit Count
- 15
- Registration Number
- NCT06942195
- Locations
- 🇦🇺
Clinical Research Facility, Adelaide Health and Medical Sciences Building, Adealide, South Australia, Australia
Prognostic Significance of CMR-Confirmed Infarct in MINOCA Patients from Sweden and Australia
Completed
- Conditions
- MINOCA
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- University of Adelaide
- Target Recruit Count
- 1000
- Registration Number
- NCT06889428
- Locations
- 🇦🇺
University of Adelaide, Adelaide, South Australia, Australia
The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)
Phase 2
Not yet recruiting
- Conditions
- Angina AttacksNon Obstructive Coronary Artery Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- University of Adelaide
- Target Recruit Count
- 25
- Registration Number
- NCT06890507
- Locations
- 🇦🇺
The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
The ARRC III Trial of Advanced Recovery Room Care (ARRC).
Recruiting
- Conditions
- Post-Surgical ComplicationEconomic Problems
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- University of Adelaide
- Target Recruit Count
- 3000
- Registration Number
- NCT05836285
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found